BIOEQUIVALENCE STUDY OF THE BIOSIMILAR RECOMBINANT HUMAN ERYTHROPOIETIN ALPHA (RENOGEN®) AND EPREX® AFTER SUBCUTANEOUS ADMINISTRATION